What check size does Brett Zbar write?

Brett Zbar typically writes checks of $100K – $5M.

Where did Brett Zbar go to school?

Brett Zbar studied at Harvard Medical School (MD, Medicine); Yale University (BA, Molecular Biophysics and Biochemistry; English).

Brett Zbar

Investor

Managing Director and Global Head of Life Sciences at General Atlantic

New York, New York

Writes $100K – $5M checks · typically $1.5M

Find your path to Brett

3,281 people in our graph share verified history with Brett — schools, employers, funds. One of them is your warm intro.

Jimena NowackunlockedBrett: together at General Atlantic (2020–2021)

×3Brett: together at McKinsey & Company

×5Brett: together at Harvard Medical School

Brett: together at General Atlantic

About

Brett Zbar is a Managing Director and Global Head of Life Sciences at General Atlantic, which he joined in 2020. He previously was a Managing Director at Foresite Capital and a Partner at Aisling Capital, focusing on healthcare and life sciences companies, and earlier worked in the Pharmaceuticals and Medical Products practice at McKinsey & Company. He holds an M.D. from Harvard Medical School and a B.A. from Yale University, and completed an internal medicine internship at Johns Hopkins Hospital.

Invests in

BiotechDigital HealthHealthtechMedical Devices

Experience

General AtlanticManaging Director and Global Head of Life Sciencescurrent2020 — presentNew York, United States
Foresite Capital ManagementManaging Director2015 — 2020Greater New York City Area
Aisling Capital LLCPartner2004 — 2014
McKinsey & CompanyAssociate Principal1999 — 2004
Johns Hopkins HospitalOsler Medical Housestaff1998 — 1999Department of Medicine

Skills & more

Corporate Development41Mergers3Start-ups15Venture Capital62Management Consulting5Emerging Markets5Growth Capital3M&A experience2LBO3Valuation8Market Entry1Business Development4

+8 more

EntrepreneurshipDue DiligenceCommercializationFinancial ModelingStrategyBusiness StrategyPrivate EquityBiotechnology

From Brett's professional profile.

Investments

Board seats

AragonCatalentConnectiveRxKinnate BiopharmaORIC PharmaceuticalsPeloton TherapeuticsPharvarisPlanet BiopharmaceuticalsReplimuneSeragonSignant HealthTurning Point TherapeuticsVenatoRx Pharmaceuticals

Per the firm's website.

Colleagues at General Atlantic

Aaron Goldman

Managing Director at General Atlantic

Adrianna Ma

Executive Officer at General Atlantic

Alex Crisses

Managing Director at General Atlantic

Andrew Crawford

Managing Director at General Atlantic

Andrew Ferrer

Managing Director at General Atlantic

Andrew Pearson

Executive Officer at General Atlantic

Anish Batlaw

Managing Director at General Atlantic

Annie Paydar

Managing Director, Global Head of Human Capital at General Atlantic

Network9

Anton LevyScout

Managing Director at General Atlantic

Steven DenningScout

Investor at General Atlantic

Vinay TrivediScout

Investor at General Atlantic

Aaron Goldman

Managing Director at General Atlantic

Alex Crisses

Managing Director at General Atlantic

Andrew Crawford

Managing Director at General Atlantic

Andrew Ferrer

Managing Director at General Atlantic

Anish Batlaw

Managing Director at General Atlantic

Ben Sherman

Principal at General Atlantic

Investors connected to Brett in public investor directories — a warm-intro map.

Frequently asked questions

Who is Brett Zbar?: Brett Zbar is a Managing Director and Global Head of Life Sciences at General Atlantic, which he joined in 2020. He previously was a Managing Director at Foresite Capital and a Partner at Aisling Capital, focusing on healthcare and life sciences companies, and earlier worked in the Pharmaceuticals and Medical Products practice at McKinsey & Company. He holds an M.D. from Harvard Medical School and a B.A. from Yale University, and completed an internal medicine internship at Johns Hopkins Hospital.
Where does Brett Zbar work?: Brett Zbar is Managing Director and Global Head of Life Sciences at General Atlantic.
What does Brett Zbar invest in?: Brett Zbar invests in Biotech, Digital Health, Healthtech, Medical Devices.
What check size does Brett Zbar write?: Brett Zbar typically writes checks of $100K – $5M.
What boards does Brett Zbar sit on?: Brett Zbar holds tracked board seats at Aragon, Catalent, ConnectiveRx, Kinnate Biopharma, ORIC Pharmaceuticals, Peloton Therapeutics, Pharvaris, Planet Biopharmaceuticals, Replimune, Seragon.
Where did Brett Zbar go to school?: Brett Zbar studied at Harvard Medical School (MD, Medicine); Yale University (BA, Molecular Biophysics and Biochemistry; English).

Same school

Also attended Harvard Medical School245

Niko BonatsosFounder and Managing Partner of Verdict Anthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital

+ 239 more

Also attended Yale University948

Ann Miura-KoCo-founding Partner at Floodgate David SzeAdvisory Partner at Greylock Michael SeibelPartner Emeritus at Y Combinator Ben SilbermannCo-founder of Pinterest Zheela QaiserInvestor at Index Ventures Anthony PhilippakisInvestor at GV (Google Ventures)

+ 942 more

Shared employers

Also worked at Foresite Capital Management37

Victoria LewisVenture Professional at Medical Excellence Capital Nick SmithChief Investor Relations Officer at S32 Rick DeweyEntrepreneur-in-Residence at Versant Ventures Christine AylwardFounder & Managing Partner at Magnetic Ventures Kunaal PatelInvestor at Acrew Capital Austin Nalen SproleDirector at Wittington Ventures

+ 31 more

Also worked at Aisling Capital LLC9

Lloyd AppelChief Financial Officer at Differential Ventures Aftab KheraniManaging Partner at Ajax Health Scott BraunsteinVice-Chairman of the Board and Director at atai Life Sciences Andrew SchiffManaging Partner at Aisling Capital Eric AguiarPartner at Aisling Capital Sunny ReddyPrincipal at Aisling Capital

+ 3 more

Also worked at McKinsey & Company2,000

Elad GilSolo general partner investing through Gil Capital Ann Miura-KoCo-founding Partner at Floodgate Jeremy LiewPartner at Lightspeed Venture Partners Mike SpeiserManaging Director at Sutter Hill Ventures Jeremy LevinePartner at Bessemer Venture Partners Fabrice GrindaCo-founder & Managing Partner at FJ Labs

+ 1,994 more

Also worked at Johns Hopkins Hospital18

Rochelle WalenskyExecutive Partner at Flare Capital Partners Rachel PhilbinVice President at Long Ridge Equity Partners Brian MullerPrincipal at Black Jays Ventures Jarred BressnerPrincipal at Activate Venture Partners Jessica ChaoInvestor at Endurance28 Tony HoInvestor at Pivotal Life Sciences

+ 12 more